Vir Biotechnology, Inc. Nonoperating Income (Expense) in USD from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Vir Biotechnology, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to Q3 2025.
  • Vir Biotechnology, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $10.5M, a 41.1% decline year-over-year.
  • Vir Biotechnology, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $49.2M, a 29.6% decline year-over-year.
  • Vir Biotechnology, Inc. annual Nonoperating Income (Expense) for 2024 was $64.1M, a 14.2% increase from 2023.
  • Vir Biotechnology, Inc. annual Nonoperating Income (Expense) for 2023 was $56.1M.
  • Vir Biotechnology, Inc. annual Nonoperating Income (Expense) for 2022 was -$78.8M, a 161% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

Vir Biotechnology, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $49.2M $10.5M -$7.29M -41.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $56.5M $7.63M -$11.1M -59.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $67.6M $18.6M +$3.52M +23.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $64.1M $12.5M -$5.78M -31.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $69.8M $17.8M -$2.34M -11.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $72.2M $18.7M +$1.18M +6.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $71M $15.1M +$14.9M +8141% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $56.1M $18.3M +$19.4M Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $36.7M $20.1M -$2.66M -11.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $39.4M $17.6M +$26.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $13.3M $183K +$92.1M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 -$78.8M -$1.14M +$24.7M +95.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$104M $22.8M -$141M -86.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $37.9M -$8.5M -$9.35M -1101% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $47.2M -$91.9M -$81.8M -812% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $129M -$25.9M -$28.6M -1049% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $158M $164M +$161M +5321% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$3.48M $849K +$2.92M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$6.4M -$10.1M -$4.77M -89.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$1.63M $2.73M +$9.49M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$11.1M $3.03M +$3.68M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$14.8M -$2.07M -$3.93M -211% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$10.9M -$5.31M -$7.41M -353% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.45M -$6.76M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$647K -$1.54M -173% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.86M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $2.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 $890K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19

Vir Biotechnology, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $64.1M +$7.95M +14.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $56.1M +$135M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$78.8M -$208M -161% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $129M +$131M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$1.63M +$1.82M +52.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$3.45M -$5.78M -248% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $2.33M +$1.61M +223% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $721K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.